FDA Decisions Expected: October 2025 Prime Therapeutics Portal New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Enforcement In 2025: What The Data Reveals So Far When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Is BPC157 Legal? WADA, FDA Status, and What You Need to Know